ReVital Cancer Rehabilitation Revenue and Competitors
Estimated Revenue & Valuation
- ReVital Cancer Rehabilitation's estimated annual revenue is currently $6.7M per year.
- ReVital Cancer Rehabilitation's estimated revenue per employee is $216,000
Employee Data
- ReVital Cancer Rehabilitation has 31 Employees.
- ReVital Cancer Rehabilitation grew their employee count by -3% last year.
ReVital Cancer Rehabilitation's People
Name | Title | Email/Phone |
---|
ReVital Cancer Rehabilitation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.8M | 61 | -3% | N/A | N/A |
#2 | $14.1M | 58 | 12% | N/A | N/A |
#3 | $468M | 1238 | 9% | N/A | N/A |
#4 | $9.7M | 45 | 2% | N/A | N/A |
#5 | $4M | 21 | 62% | N/A | N/A |
#6 | $6.5M | 30 | 0% | N/A | N/A |
#7 | $14.8M | 61 | 13% | N/A | N/A |
#8 | $62.1M | 209 | 3% | N/A | N/A |
#9 | $8.4M | 39 | 11% | N/A | N/A |
#10 | $33.5M | 124 | 1% | N/A | N/A |
What Is ReVital Cancer Rehabilitation?
ReVital is a groundbreaking rehabilitation program that empowers those affected by cancer and its treatment to live their best lives. Our cancer-certified caregivers support quicker, more complete patient recoveries with physical and occupational therapy, speech-language pathology, and neuropsychology. With many patients, this also means restored strength, reduced pain, less swelling, and improved mobility. Developed by Select Medical, a leading provider of post-acute care, ReVital currently serves patients in over 350 locations across more than 15 states. Learn more on our website, revitalcancerrehab.com Live well beyond cancer, we say! ðŸ™ðŸ¾
keywords:N/AN/A
Total Funding
31
Number of Employees
$6.7M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.2M | 31 | 0% | N/A |
#2 | N/A | 31 | -3% | N/A |
#3 | $6.7M | 31 | 0% | N/A |
#4 | $4.1M | 32 | 146% | N/A |
#5 | $6.6M | 33 | -6% | N/A |